# Pioglitazone Attenuates Dysmetabolism in Peritoneal Dialysis (PD) Patients

> **NCT01258322** · NA · COMPLETED · sponsor: **Huashan Hospital** · enrollment: 70 (actual)

## Conditions studied

- Peritoneal Dialysis
- Pioglitazone
- Hypertriglyceridemia
- Insulin Resistance
- Inflammation

## Interventions

- **DRUG:** Pioglitazone

## Key facts

- **NCT ID:** NCT01258322
- **Lead sponsor:** Huashan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2010-12-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01258322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01258322, "Pioglitazone Attenuates Dysmetabolism in Peritoneal Dialysis (PD) Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01258322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*